BFM Podcast

Duopharma Seeking to Diversify Manufacturing Domain

Tan KW
Publish date: Wed, 13 Mar 2024, 01:38 PM
Duopharma Seeking to Diversify Manufacturing Domain

13-Mar-24 08:00

Leonard Ariff Abdul Shatar, Group Managing Director, Duopharma Biotech

Malaysian pharmaceutical Duopharma Biotech achieved their best financial performance to date in 2022, reaching record highs for revenue and profit. However 2023 was not as kind, with profit after tax falling by 25% despite top line growth. How are they looking to reverse course in 2024? We discuss strategy with Group Managing Director Leonard Ariff Abdul Shatar.

Related Stocks
Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment